Efficacy profiles of antimicrobials evaluated against Staphylococcus species isolated from canine clinical specimens

Show simple item record

dc.contributor.author Qekwana, Daniel Nenene
dc.contributor.author Odoi, Agricola
dc.contributor.author Oguttu, James Wabwire
dc.date.accessioned 2022-02-01T09:56:08Z
dc.date.available 2022-02-01T09:56:08Z
dc.date.issued 2021-11-12
dc.description.abstract Cross-resistance occurs between antimicrobials with either similar mechanisms of action and/or similar chemical structures, or even between unrelated antimicrobials. This study employed a multivariate approach to investigate the associations between the efficacy profile of antimicrobials and the clustering of eleven different antimicrobial agents based on their efficacy profile. Records of the susceptibility of 382 confirmed Staphylococcus species isolates against 15 antimicrobials based on the disc diffusion method were included in this study. Tetrachoric correlation coefficients were computed to assess the correlations of antimicrobial efficacy profiles against Staphylococcus aureus. Principal components analysis and factor analysis were used to assess the clustering of antimicrobial susceptibility profiles. Strong correlations were observed among aminoglycosides, penicillins, fluroquinolones, and lincosamides. Three main factors were extracted, with Factor 1 dominated by the susceptibility profile of enrofloxacin (factor loading (FL) = 0.859), gentamicin (FL = 0.898), tylosin (FL = 0.801), and ampicillin (FL = 0.813). Factor 2, on the other hand, was dominated by the susceptibility profile of clindamycin (FL = 0.927) and lincomycin-spectinomycin (FL = 0.848) and co-trimazole (FL = 0.693). Lastly, Factor 3 was dominated by the susceptibility profile of amoxicillin-clavulanic acid (FL = 0.848) and cephalothin (FL = 0.824). Antimicrobials belonging to the same category or class of antimicrobial, tended to exhibit similar efficacy profiles, therefore, laboratories must choose only one of the antimicrobials in each group to help reduce the cost of antimicrobial susceptibility tests. en_ZA
dc.description.department Paraclinical Sciences en_ZA
dc.description.librarian am2022 en_ZA
dc.description.uri https://www.mdpi.com/journal/animals en_ZA
dc.identifier.citation Qekwana, D.N.; Odoi, A.; Oguttu, J.W. Efficacy Profiles of Antimicrobials Evaluated against Staphylococcus Species Isolated from Canine Clinical Specimens. Animals 2021, 11, 3232. https://DOI.org/10.3390/ani11113232. en_ZA
dc.identifier.issn 2076-2615
dc.identifier.other 10.3390/ani11113232
dc.identifier.uri http://hdl.handle.net/2263/83555
dc.language.iso en en_ZA
dc.publisher MDPI en_ZA
dc.rights © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. en_ZA
dc.subject Efficacy en_ZA
dc.subject Staphylococcus en_ZA
dc.subject Factor analysis en_ZA
dc.subject Eigenvalues en_ZA
dc.subject Principal components analysis (PCA) en_ZA
dc.subject Antimicrobial resistance (AMR) en_ZA
dc.title Efficacy profiles of antimicrobials evaluated against Staphylococcus species isolated from canine clinical specimens en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record